Dual GIP/GLP-1 Drug Linked to Fewer Deaths in Real-World Liver Disease Study

(MedPage Today) — PHOENIX — Use of tirzepatide (Mounjaro, Zepbound) was associated with significantly lower risks of death, hospitalization, and major cardiovascular events compared with semaglutide (Ozempic, Wegovy) in high-risk patients with…

Source link : https://www.medpagetoday.com/meetingcoverage/acg/118194

Author :

Publish date : 2025-10-28 21:11:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Dual GIP/GLP-1 Drug Linked to Fewer Deaths in Real-World Liver Disease Study

Quantum-inspired algorithm could help reveal hidden cosmic objects

Difficult-to-Treat Rheumatoid Arthritis: Is Prevention Feasible?

Related Posts

Could AI Help Predict the Next Pandemic?

Serum Haptoglobin: A Prognostic Biomarker for Urticaria?

GLP-1 Drugs Tied to Lower CRC Risk and Better Outcomes

ED Mental Health Bundle Boosts Disability Support, Not FQOL

EU Fluoride Exposure Deemed Safe as Regulators Review Limits

Regional Anesthesia: Key to Better Postoperative Outcomes?

Could AI Help Predict the Next Pandemic?

Serum Haptoglobin: A Prognostic Biomarker for Urticaria?

GLP-1 Drugs Tied to Lower CRC Risk and Better Outcomes

ED Mental Health Bundle Boosts Disability Support, Not FQOL

EU Fluoride Exposure Deemed Safe as Regulators Review Limits

Regional Anesthesia: Key to Better Postoperative Outcomes?

Sooner-than-expected climate impacts could cost the world trillions

First leukaemia patient to get pioneering drug on NHS says it is ‘very sci-fi’

Categories

Archives